Dopamine agonist responsive burning mouth syndrome: Report of eight cases. [PDF]
Du QC, Ge YY, Xiao WL, Wang WF.
europepmc +1 more source
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? [PDF]
De Sousa SMC.
europepmc +1 more source
Toward Understanding the Biology of a Complex Phenotype: Rat Strain and Substrain Differences in the Sensorimotor Gating-Disruptive Effects of Dopamine Agonists [PDF]
Neal R. Swerdlow +7 more
openalex +1 more source
Does Intravitreal Dopamine Agonist and Antagonist Administration Have Effects on the Brain? An Experimental Study in Rats. [PDF]
Kocak MN +6 more
europepmc +1 more source
Macroprolactinoma Shrinkage during Cabergoline Treatment Is Greater in Naive Patients Than in Patients Pretreated with Other Dopamine Agonists: A Prospective Study in 110 Patients1 [PDF]
Annamaria Colao +10 more
openalex +1 more source
Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine. [PDF]
Clausen MF +8 more
europepmc +1 more source
UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes [PDF]
Christopher G. V. Sharples +10 more
openalex +1 more source
Change in Insulin Sensitivity and Lipid Profile After Dopamine Agonist Therapy in Patients With Prolactinoma. [PDF]
Khalil G +5 more
europepmc +1 more source
Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas. [PDF]
Mignone E +4 more
europepmc +1 more source

